BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 361587)

  • 1. Distribution of fenfluramine in normal and obese mice.
    Bizzi A; Tacconi MT; Tognoni G; Morselli PL; Garattini S
    Int J Obes; 1978; 2(1):1-5. PubMed ID: 361587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of d-fenfluramine and its metabolite, d-norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies.
    Richards RP; Gordon BH; Ings RM; Campbell DB; King LJ
    Xenobiotica; 1989 May; 19(5):547-53. PubMed ID: 2750211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-obesity activity of 3-hydroxymethyl N-methyl piperidine 4-chlorophenoxyacetate hydrochloride in mice treated with gold thioglucose].
    Massicot F; Arapis G; Falcou R; Apfelbaum M; Godfroid JJ
    C R Acad Sci III; 1986; 303(17):703-8. PubMed ID: 3101985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of mazindol in preventing onset and development of obesity induced by gold thioglucose injection.
    Kawano-Takahashi Y; Ohminaji H; Ubagai E; Okuda H
    Int J Obes; 1984; 8(6):655-64. PubMed ID: 6442712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days.
    Caccia S; Conforti I; Duchier J; Garattini S
    Eur J Clin Pharmacol; 1985; 29(2):221-4. PubMed ID: 4076322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
    Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fenfluramine on weight loss during restricted dietary regimes.
    Wales JK
    Int J Obes; 1980; 4(2):127-32. PubMed ID: 7399803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss].
    Magnoni V; Boni S; Bonini LM; Zecca L; Bareggi SR
    Minerva Med; 1982 Jun; 73(24):1703-10. PubMed ID: 7088388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fenfluramine levels, weight loss, and side effects.
    Innes JA; Watson ML; Ford MJ; Munro JF; Stoddart ME; Campbell DB
    Br Med J; 1977 Nov; 2(6098):1322-5. PubMed ID: 589167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.
    Mennini T; Bizzi A; Caccia S; Codegoni A; Fracasso C; Frittoli E; Guiso G; Padura IM; Taddei C; Uslenghi A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):483-90. PubMed ID: 1881458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective gas chromatographic assay with electron-capture detection for dl-fenfluramine and dl-norfenfluramine in plasma.
    Srinivas NR; Hubbard JW; Cooper JK; Midha KK
    J Chromatogr; 1988 Dec; 433():105-17. PubMed ID: 3235539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of N-nitrosofenfluramine after its administration to rats.
    Kaddoumi A; Wada M; Nakashima K
    Biomed Chromatogr; 2011 May; 25(5):579-87. PubMed ID: 20857399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue [1-14C] 2-deoxyglucose metabolism in the gold thioglucose obese mouse: effects of 'dieting'.
    Steinbeck KS; Caterson ID; Cooney GJ
    Int J Obes Relat Metab Disord; 1994 Mar; 18(3):167-72. PubMed ID: 8186814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of fenfluramine in treatment of obesity.
    Douglas JG; Gough J; Preston PG; Frazer I; Haslett C; Chalmers SR; Munro JF
    Lancet; 1983 Feb; 1(8321):384-6. PubMed ID: 6130379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration.
    Campbell DB; Turner P
    Br J Pharmacol; 1971 Oct; 43(2):465P-466P. PubMed ID: 5158239
    [No Abstract]   [Full Text] [Related]  

  • 16. Disposition of (-)-fenfluramine and its active metabolite, (-)-norfenfluramine in rat: a single dose-proportionality study.
    Spinelli R; Fracasso C; Guiso G; Garattini S; Caccia S
    Xenobiotica; 1988 May; 18(5):573-84. PubMed ID: 3400275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas-liquid chromatographic determination of the optical isomers of fenfluramine and norfenfluramine in biological samples.
    Caccia S; Jori A
    J Chromatogr; 1977 Nov; 144(1):127-31. PubMed ID: 914957
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: The relationship between fenfluramine and norfenfluramine blood levels and anoretic activity in the rat.
    Blundell JE; Campbell DB
    Br J Pharmacol; 1975 Oct; 55(2):261P. PubMed ID: 1201401
    [No Abstract]   [Full Text] [Related]  

  • 19. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain.
    Clausing P; Newport GD; Bowyer JF
    J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of iprindole with fenfluramine metabolism in rat brain and liver.
    Hegadoren KM; Baker GB; Coutts RT; Dewhurst WG
    J Psychiatry Neurosci; 1991 Mar; 16(1):5-11. PubMed ID: 2049371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.